Fused heterocyclic compounds and their use
US9550764B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2013 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Aug 22, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.